Beta-adrenergic drugs and risk of Parkinson’s disease: A systematic review and meta-analysis

Ambrish Singh, Benny Antony(University of Tasmania), Sreelatha Akkala, Miloslav Klugar(Palacký University Olomouc), Bruce Taylor(University of London), Julie A. Campbell(Harvard University), Salman Hussain(European CanCer Organisation), Jitka Klugarová(Masaryk University), Andrea Pokorná(Masaryk University), Ingrid Hopper(The Alfred Hospital), E. Haydn Walters(University of Tasmania)

Ageing Research Reviews

June 17, 2022

10.1016/j.arr.2022.101670

Cited by 17

Related Papers

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

|The Lancet|2021|1.7k

Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021

|The Lancet Rheumatology|2023|1.7k

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

|Neurology|2014|1.3k

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

|The Lancet|2017|734

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

|The Lancet Rheumatology|2023|632